Coelho, R.A.; Figueiredo-Carvalho, M.H.G.; Almeida-Silva, F.; de Souza Rabello, V.B.; de Souza, G.R.; Sangenito, L.S.; Joffe, L.S.; Santos, A.L.S.d.; da Silva Lourenço, M.C.; Rodrigues, M.L.;
et al. Repurposing Benzimidazoles against Causative Agents of Chromoblastomycosis: Albendazole Has Superior In Vitro Activity Than Mebendazole and Thiabendazole. J. Fungi 2023, 9, 753.
https://doi.org/10.3390/jof9070753
AMA Style
Coelho RA, Figueiredo-Carvalho MHG, Almeida-Silva F, de Souza Rabello VB, de Souza GR, Sangenito LS, Joffe LS, Santos ALSd, da Silva Lourenço MC, Rodrigues ML,
et al. Repurposing Benzimidazoles against Causative Agents of Chromoblastomycosis: Albendazole Has Superior In Vitro Activity Than Mebendazole and Thiabendazole. Journal of Fungi. 2023; 9(7):753.
https://doi.org/10.3390/jof9070753
Chicago/Turabian Style
Coelho, Rowena Alves, Maria Helena Galdino Figueiredo-Carvalho, Fernando Almeida-Silva, Vanessa Brito de Souza Rabello, Gabriela Rodrigues de Souza, Leandro Stefano Sangenito, Luna Sobrino Joffe, André Luis Souza dos Santos, Maria Cristina da Silva Lourenço, Marcio L. Rodrigues,
and et al. 2023. "Repurposing Benzimidazoles against Causative Agents of Chromoblastomycosis: Albendazole Has Superior In Vitro Activity Than Mebendazole and Thiabendazole" Journal of Fungi 9, no. 7: 753.
https://doi.org/10.3390/jof9070753
APA Style
Coelho, R. A., Figueiredo-Carvalho, M. H. G., Almeida-Silva, F., de Souza Rabello, V. B., de Souza, G. R., Sangenito, L. S., Joffe, L. S., Santos, A. L. S. d., da Silva Lourenço, M. C., Rodrigues, M. L., & Almeida-Paes, R.
(2023). Repurposing Benzimidazoles against Causative Agents of Chromoblastomycosis: Albendazole Has Superior In Vitro Activity Than Mebendazole and Thiabendazole. Journal of Fungi, 9(7), 753.
https://doi.org/10.3390/jof9070753